JP2024544566A5 - - Google Patents
Info
- Publication number
- JP2024544566A5 JP2024544566A5 JP2024528594A JP2024528594A JP2024544566A5 JP 2024544566 A5 JP2024544566 A5 JP 2024544566A5 JP 2024528594 A JP2024528594 A JP 2024528594A JP 2024528594 A JP2024528594 A JP 2024528594A JP 2024544566 A5 JP2024544566 A5 JP 2024544566A5
- Authority
- JP
- Japan
- Prior art keywords
- lentiviral vector
- acid sequence
- nucleic acid
- antigen
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21306581 | 2021-11-15 | ||
| EP21306581.6 | 2021-11-15 | ||
| US202163279945P | 2021-11-16 | 2021-11-16 | |
| US63/279,945 | 2021-11-16 | ||
| EP22306119.3 | 2022-07-27 | ||
| EP22306119 | 2022-07-27 | ||
| PCT/EP2022/081839 WO2023084094A1 (en) | 2021-11-15 | 2022-11-14 | Lentiviral vectors for expression of human papillomavirus (hpv) antigens and its implementation in the treatment of hpv induced cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024544566A JP2024544566A (ja) | 2024-12-03 |
| JP2024544566A5 true JP2024544566A5 (https=) | 2025-10-14 |
Family
ID=84536137
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024528594A Pending JP2024544566A (ja) | 2021-11-15 | 2022-11-14 | ヒトパピローマウイルス（ｈｐｖ）抗原の発現の為のレンチウイルスベクター、並びにｈｐｖ誘発癌の処置におけるその実施 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240415951A1 (https=) |
| EP (1) | EP4433081A1 (https=) |
| JP (1) | JP2024544566A (https=) |
| KR (1) | KR20240124919A (https=) |
| AU (1) | AU2022386715A1 (https=) |
| CA (1) | CA3238020A1 (https=) |
| WO (1) | WO2023084094A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024023135A1 (en) * | 2022-07-27 | 2024-02-01 | Theravectys | Lentiviral vectors for expression of human papillomavirus (hpv) antigens and its implementation in the treatment of hpv induced cancers |
| CN116286982B (zh) * | 2022-09-09 | 2024-01-30 | 广州凯普医药科技有限公司 | 一种hpv基因分型检测阳性参考品及其制备方法和应用 |
| CN118344491B (zh) * | 2024-05-03 | 2025-02-14 | 华中科技大学同济医学院附属同济医院 | 一种hpv16/18治疗性疫苗、制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69941703D1 (de) | 1999-10-11 | 2010-01-07 | Pasteur Institut | Lentivirale Vektoren für die Herstellung von immunotherapeutischen Zusammensetzungen |
| DK2185192T3 (en) * | 2007-08-03 | 2019-02-18 | Pasteur Institut | LENTIVIRAL TRANSFER VECTORS AND THEIR MEDICAL USES |
| CN113846062B (zh) | 2014-07-25 | 2025-02-21 | 赛拉福柯蒂斯公司 | 用于嵌合抗原受体分子的调控表达的慢病毒载体 |
-
2022
- 2022-11-14 JP JP2024528594A patent/JP2024544566A/ja active Pending
- 2022-11-14 WO PCT/EP2022/081839 patent/WO2023084094A1/en not_active Ceased
- 2022-11-14 CA CA3238020A patent/CA3238020A1/en active Pending
- 2022-11-14 AU AU2022386715A patent/AU2022386715A1/en active Pending
- 2022-11-14 KR KR1020247019939A patent/KR20240124919A/ko active Pending
- 2022-11-14 EP EP22823328.4A patent/EP4433081A1/en active Pending
- 2022-11-14 US US18/706,610 patent/US20240415951A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024544566A5 (https=) | ||
| US8143054B2 (en) | Fusion protein of HIV regulatory/accessory proteins | |
| Robinson | New hope for an AIDS vaccine | |
| JP2019526580A5 (https=) | ||
| US20190184011A1 (en) | Methods and compositions for inducing an immune response against hepatitis b virus (hbv) | |
| CN102046785A (zh) | 基于慢病毒的免疫原性载体 | |
| Yu et al. | A recombinant pseudotyped lentivirus expressing the envelope glycoprotein of hantaan virus induced protective immunity in mice | |
| US20190151437A1 (en) | Combination prime: boost therapy | |
| Malkevitch et al. | A call for replicating vector prime-protein boost strategies in HIV vaccine design | |
| CN104039968B (zh) | 非b亚型gag蛋白在慢病毒包装中的应用 | |
| JP2021506300A (ja) | Ｂ型肝炎ウイルス（ｈｂｖ）に対する免疫応答を誘導するための方法および組成物 | |
| JP2023550480A5 (https=) | ||
| Liu et al. | The effects of HIV Tat DNA on regulating the immune response of HIV DNA vaccine in mice | |
| Xu et al. | Prime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques | |
| Tallet et al. | Sequence variations in the amino-and carboxy-terminal parts of the surface envelope glycoprotein of HTLV type 1 induce specific neutralizing antibodies | |
| RU2697781C2 (ru) | Вспомогательный плазмидный лентивирусный экспрессионный вектор для получения высоких титров vpx-содержащих лентивирусных частиц, обеспечивающий эффективное заражение моноцитов и дендритных клеток человека | |
| during Assembly | Polyprotein Processing | |
| Letvin et al. | A Human T-Cell Leukemia Virus Type | |
| CN118354790A (zh) | 用于表达人乳头瘤病毒(hpv)抗原的慢病毒载体及其在治疗hpv诱发癌症中的应用 | |
| McKenna | Characterization and immunogenicity of recombinant rhabdoviral vaccine vectors expressing HIV-1 and SIV envelope proteins | |
| Cohen | ANIMAL VIRUSES | |
| Ertl et al. | Induction of CD8+ T Cells to an HIV-1 | |
| JP2010248179A (ja) | 医薬組成物 | |
| JP2001169784A (ja) | Ｄｎａワクチン |